No phaseCompletedAge-related condition
CyanthOx™ Capsule Efficacy Study
Clinical Study Plan for CyanthOx™ Hard Capsule
- Sponsor
- Chia Nan University of Pharmacy ＆ Science (Academic or other)
- Enrolment
- 40 enrolled
- Conditions
- Skin Aging; Hair and Scalp Health; Hair Loss
- Interventions
- Placebo Group; CyanthOx™80 Group
- Ages
- adults, older adults
- Registry
- NCT07774117
Full record on ClinicalTrials.gov
From the registry
The goal of this clinical trial is to learn whether daily intake of CyanthOx™80 capsules can improve skin, scalp, hair, and selected blood biomarkers in healthy adults after 12 weeks. Researchers will compare participants who take CyanthOx™80 with participants who take a placebo to evaluate its effectiveness and tolerability. A total of 40 participants will be randomly assigned to the CyanthOx™80 group or placebo group, with 20 participants in each group. Participants will not know which capsule they receive. Participants will: Take one capsule daily for 12 weeks. Attend study visits at baseline and weeks 4, 8, and 12. Undergo non-invasive facial skin assessments at baseline, week 4, and week 12. Undergo scalp and hair assessments at baseline and weeks 4, 8, and 12. Provide a 10 mL blood sample at baseline and week 12 for tests related to antioxidant capacity, inflammation, aging, collagen, and blood lipids. Complete questionnaires about skin condition and product satisfaction. Provide collected shed hair at weeks 4, 8, and 12. Have facial, scalp, and hair photographs taken.…
Primary outcomes
- Change in Blood Biomarkers (TEAC)
- Change in Hair and Scalp Condition (hair-root diameter)
- Change in Hair and Scalp Condition (hair strength)
- Change in Hair and Scalp Condition (hair elasticity)
History
Last registry update
Registered
Study completion
Primary completion
Started